Found 11 matching trials
Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
PHASE3This is a study to look at the effectiveness, tolerability, and safety of o...
Location
Margolin Brain Institute
Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
PHASE3Study for patients currently using Levodopa/Carbidopa who will be assigned ...
Location
Rush - Presbyterian St. Luke's Medical Center
Azilect® In Wearing-Off (AIWO)
N/AEnd-of-dose fluctuations e. g. wearing-off are defined as a recurrence of m...
Location
Teva Investigational Sites
Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea
PHASE3To evaluate the efficacy of a fixed dose of Azilect® (1 mg/day) vs placebo ...
Location
Multiple Locations
Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations
PHASE3The objective of this study is to evaluate the efficacy, tolerability, and ...
Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.
PHASE3Study to look at the effectiveness, tolerability and safety of two doses of...
Location
Margolin Brain Institute
Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
PHASE3The rationale for conducting this study is to evaluate the efficacy, tolera...
Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China
PHASE3Rasagiline has been developed for the treatment of Parkinson's Disease (PD)...
Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
PHASE3Study to look at the effectiveness, tolerability and safety of two doses of...
Location
Multiple Locations
A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
PHASE4Patients with Parkinson's Disease (PD) will be divided into 2 groups at eac...
Location
Multiple Locations